Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Matthias Anders"'
Autor:
Peter Kovacs, Joachim Beige, Matthias Anders, Matthias Blüher, Mathias Fasshauer, Anke Tönjes, Markus Scholz, Ronny Baber, Dorit Schleinitz, Markus Löffler, Nora Klöting, Sabine Paeschke, Annett Hoffmann, Ingolf Bast, Cornelia Enzenbach, Abdul Rashid Qureshi, Peter Stenvinkel, Michael Stumvoll, Marcin Nowicki, Raymond C. Harris, Thomas Ebert, Anette Bachmann, Ming-Zhi Zhang, Susan Kralisch, Jürgen Kratzsch, Kerstin Wirkner
Publikováno v:
Eur. J. Endocrinol. 183, 233-244 (2020)
Background: Patients with chronic kidney disease (CKD) have a high risk of premature cardiovascular diseases (CVD) and show increased mortality. Pro-neurotensin (Pro-NT) was associated with metabolic diseases and predicted incident CVD and mortality.
Circulating adipocyte fatty acid binding protein is increased in chronic and acute renal dysfunction
Autor:
Michael Stumvoll, Joachim Beige, O. Grisk, Matthias Anders, Anja Dietel, Ulrike Wurst, Ulrike Lossner, Juergen Kratzsch, Thomas Ebert, J.U. Stolzenburg, Anette Bachmann, LM Hopf, Susan Kralisch, Ingolf Bast, Nora Klöting, Martin Platz, Matthias Blüher, Mathias Fasshauer
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 24:1027-1034
Background and aims The adipokine adipocyte fatty acid binding protein (AFABP) is positively associated with the development of the metabolic syndrome, diabetes mellitus, and cardiovascular disease. We hypothesized that AFABP also increases with dete
Autor:
Denise Focke, Ulrike Lossner, Thomas Ebert, Susan Kralisch, Ingolf Bast, Juergen Kratzsch, Matthias Blüher, Joachim Beige, Matthias Anders, Mathias Fasshauer, Ulrike Wurst, David Petroff, Michael Stumvoll, J Richter, Anette Bachmann
Publikováno v:
European Journal of Endocrinology. 170:501-506
ObjectiveIrisin has recently been introduced as a novel myokine which reverses visceral obesity and improves glucose metabolism in mice. However, regulation of irisin in humans in relation to renal and metabolic disease has not been comprehensively s
Autor:
J Richter, Ulrike Lossner, Denise Focke, Anette Bachmann, Jürgen Kratzsch, Peter Kovacs, Joachim Beige, Matthias Anders, Susan Kralisch, Michael Stumvoll, Matthias Blüher, Mathias Fasshauer, Thomas Ebert, Ingolf Bast
Publikováno v:
Diabetes Care
OBJECTIVE Progranulin has recently been introduced as a novel adipokine inducing insulin resistance and obesity. In the current study, we investigated renal elimination, as well as association of the adipokine with markers of the metabolic syndrome.
Autor:
Susan Kralisch, Ingolf Bast, Michael Stumvoll, Thomas Ebert, Jürgen Kratzsch, Annett Hoffmann, Ming-Zhi Zhang, Anja Dietel, Joachim Beige, Matthias Anders, Jens-Uwe Stolzenburg, Raymond C. Harris, Matthias Blüher, Mathias Fasshauer, Nora Klöting, Anette Bachmann
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 32(10)
Background Follistatin-like 3 (FSTL3) is a novel cytokine that regulates insulin sensitivity and counteracts activin/myostatin signalling. In the present study, regulation of FSTL3 in renal dysfunction was investigated in both human chronic kidney di
Autor:
Matthias Blüher, Mathias Fasshauer, Thomas Ebert, J.U. Stolzenburg, A Dietel, Anette Bachmann, U Lößner, Michael Stumvoll, Joachim Beige, Matthias Anders, LM Hopf, Ulrike Wurst, Juergen Kratzsch, Ingolf Bast, Susan Kralisch
Publikováno v:
Diabetologie und Stoffwechsel. 9
Autor:
Jürgen Kratzsch, Matthias Blüher, Jens-Uwe Stolzenburg, Mathias Fasshauer, Thomas Ebert, Janka Hindricks, Anja Dietel, Anette Bachmann, Michael Stumvoll, Joachim Beige, Matthias Anders, Ingolf Bast, Ulrike Lossner, Susan Kralisch
Publikováno v:
Clinical endocrinology. 80(6)
SummaryObjective Fibroblast growth factor (FGF)-21 has recently been introduced as a circulating adipokine which reverses insulin resistance and obesity in rodents. In this study, regulation of FGF-21 in renal dysfunction was elucidated in both chron
Publikováno v:
Anesthesiology. 88(3)
Background Sevoflurane undergoes Baralyme- or soda lime-catalyzed degradation in the anesthesia circuit to yield compound A (2-[fluoromethoxy]-1,1,3,3,3-pentafluroro-1-propene), which is nephrotoxic in rats and undergoes metabolism via the cysteine c